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Abstract
Background: DNA double-strand breaks (DSBs) caused by ionizing radiation or by the stalling of DNA replication
forks are among the most deleterious forms of DNA damage. The ability of cells to recognize and repair DSBs
requires post-translational modifications to histones and other proteins that facilitate access to lesions in
compacted chromatin, however our understanding of these processes remains incomplete. UHRF1 is an E3
ubiquitin ligase that has previously been linked to events that regulate chromatin remodeling and epigenetic
maintenance. Previous studies have demonstrated that loss of UHRF1 increases the sensitivity of cells to DNA
damage however the role of UHRF1 in this response is unclear.
Results: We demonstrate that UHRF1 plays a critical role for facilitating the response to DSB damage caused by g-
irradiation. UHRF1-depleted cells exhibit increased sensitivity to g-irradiation, suggesting a compromised cellular
response to DSBs. UHRF1-depleted cells show impaired cell cycle arrest and an impaired accumulation of histone
H2AX phosphorylation (gH2AX) in response to g-irradiation compared to control cells. We also demonstrate that
UHRF1 is required for genome integrity, in that UHRF1-depleted cells displayed an increased frequency of
chromosomal aberrations compared to control cells.
Conclusions: Our findings indicate a critical role for UHRF1 in maintenance of chromosome integrity and an
optimal response to DSB damage.
Background
UHRF1 (also known as Np95 and ICBP90) was origin-
ally identified as a protein whose subcellular expression
pattern coincided with sites of DNA replication [1-3].
Further studies supported a role for this protein in S
phase progression, particularly in replication of hetero-
chromatin regions surrounding centromeres known as
pericentric heterochromatin [4-6]. This role in hetero-
chromatin replication and maintenance is linked to the
ability of UHRF1 to facilitate several epigenetic modifi-
cations of histones and DNA [5-7]. UHRF1 binds to and
ubiquitinates histone H3 [7,8] and facilitates deacetyla-
tion of lysine 8, 12, and 16 of heterochromatin histone
H4 [6,9]. The SET and RING associated (SRA) domain
of UHRF1 binds to hemi-methylated DNA and plays a
crucial role in copying pre-existing methylation patterns
onto newly replicated DNA by recruiting the DNA
methyltransferase Dnmt1 to replication sites [10-14]. In
addition to its function in duplicating DNA methylation
patterns, UHRF1 binds to histone H3 tri-methylated at
lysine 9 (H3K9me3) and plays a role in maintaining this
histone modification in heterochromatin [7]. A recent
study has pointed to the importance of a tandem tudor
domain for UHRF1 binding to H3K9me3 [15].
Several studies have now identified a role for UHRF1
in the maintenance of heterochromatin modifications
independent of its role in DNA replication. UHRF1 acts
to facilitate promoter silencing [9,16-19]. This ability to
repress transcription has been linked to UHRF1’s
recruitment of G9a histone methyltransferase and DNA
methyltransferases Dnmt3a/b that repress transcription
in euchromatin through the dimethylation of H3K9 and
DNA methylation respectively [17,18].
Previous studies have demonstrated a critical role for
UHRF1 in the cellular response to a wide range of sti-
muli that result in DNA damage. Murine embryonic
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sensitive to x-rays, UV light, base damaging agents and
hydroxyurea than wild-type cells [20]. Ablation of
human UHRF1 results in hypersensitivity to X-rays, UV
light and hydroxyurea [21]. Despite these observations,
the mechanism whereby UHRF1 confers a protective
role to various genotoxic stresses remains unclear. In
this study, we identify a novel role for this protein as a
genome caretaker and demonstrate that the hypersensi-
tivity of UHRF1-depleted cells to irradiation can be
attributed to an impaired ability to mount an optimal
DNA damage response.
Materials and methods
Cell lines
Human HeLa cells (ATCC) with diminished expression
of UHRF1 were selected for resistance to puromycin
following stable transfection with either HuSH 29mer
short hairpin RNA (shRNA) constructs against UHRF1
(5’-AGG AGA CGT TCC AGT GTA TCT GCT GTC
AG-3’ and ‘5 - T T CG T GG A CG A AG T CT T CA A G
ATT GAG CG-3’) or with a control shRNA plasmid
(pRS-shGFP, non-effective, Origene), together with a
vector conferring puromycin resistance. Three cloned
cell lines expressing UHRF1 shRNA that demonstrated
decreased levels of UHRF1, together with three cell
lines transfected with control vector were selected for
further analysis. Growth of individual cell lines was
monitored by seeding cells at 3.5 × 10
5/dish in tripli-
cate and counting cell numbers using a hemacytometer
at three day intervals. Growth curves show the cumu-
lative mean cell number ± standard deviation of five
counts.
Western blotting
For Western analysis, cells were lysed in RIPA buffer (50
mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM PMSF, 1
mM EDTA, 1% Triton X-100, 1% sodium deoxycholate,
0.1% SDS, 5 μg/ml aprotinin, 5 μg/ml leupeptin, and 5
μg/ml pepstatin). Protein quantitation was determined
by Bradford assay. Protein samples were resolved using
10% SDS-PAGE gels and transferred onto PVDF mem-
brane overnight at 4°C. Membranes were blocked in
Tris Buffered Saline with 5% milk and 0.1% Tween for 1
h at room temperature. Membranes were immuno-
blotted with the following primary antibodies diluted in
Tris Buffered Saline with 5% milk and 0.1% Tween over-
night at 4°C: polyclonal anti-tubulin (Sigma), monoclo-
nal anti-UHRF1 (BD Bioscience) followed by 1 h
incubation at room temperature with the appropriate
secondary antibody: anti-rabbit HRP-linked IgG or anti-
mouse HRP-linked IgG (GE Healthcare). Protein detec-
tion was performed using the ECL Western blotting
detection system (GE Healthcare) and exposed to scien-
tific imaging film (Bioflex).
Indirect Immunofluorescence and micronuclei analysis
HeLa cells were seeded onto coverslips (5 × 10
4/cover-
slip) pre-coated with 1% gelatin and 1% BSA. Following
fixation in methanol/acetone and permeabilization with
0.4% Triton-X in PBS for 20 min, cells were blocked
( 1 %d o n k e ys e r u m / 0 . 2 %T r i t o n - X )f o r2 0m i na n dt h e n
incubated overnight with either anti-histone H3 tri-
methylated on lysine 9 (anti-H3K9me3) or anti-histone
H4 trimethylated on lysine 20 (anti-H4K20me3) over-
night at 4°C (Millipore). Cells were then incubated with
TRITC-conjugated secondary antibodies, counterstained
with 4,6-diamidino-2-phenylindole (DAPI) and mounted
with Vectashield (Vector laboratories). Images were
acquired using an Imager.Z1 epifluorescence microscope
and Axiovision software (Zeiss) following deconvolution.
For micronuclei analysis, three UHRF1-depleted cell
lines and three control cell lines were scored for the
presence of micronuclei in triplicate, with each determi-
nation scoring > 200 cells.
Clonogenic assay
Fixed amounts of cells exposed to varying doses of
g-irradiation (Nordion Gamma-cell, Ontario Cancer
Institute) were seeded in 60 mm dishes in Dulbecco’s
Minimum Essential Media supplemented with 10% fetal
bovine serum (Invitrogen). Cells were left to form colo-
nies for seven days. Colonies were fixed and stained
with methylene blue in methanol. All survival curves
were produced from an average ± standard deviation of
three to six determinations and are presented as a per-
cent of control (non-irradiated) cells.
Flow cytometry
Cell-cycle analysis by bromodeoxyuridine (BrdU) and
propidium iodide (PI) double staining was conducted
essentially as described previously [22]. Cells (5 × 10
5/
100 mm dish) exposed to 0, 1 or 5 Gy were collected
and fixed in 70% ethanol at 0, 1, 3, 6, 12 or 24 h after
exposure and stored at -20°C prior to analysis. Measure-
ment of gH2AX and PI double staining by flow cytome-
try was performed as described previously, but with the
following modifications [22]. Cells were fixed in ice-cold
70% ethanol for 20 min, rinsed in PBS and gently vor-
texed in PBS + 0.4% TritonX for 15 min, then rinsed in
PBS. Cells were then incubated with anti-gH2AX (1:200
of 05-636, Millipore) in the dark for 3 h at room tem-
perature in 0.2% TritonX/1% donkey serum. After 1
rinse in PBS, cells were then incubated in anti-mouse
FITC (1:200, Jackson ImmunoResearch Labs) for 30 min
at room temperature. After 1 rinse in PBS, cells were
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temperature, then analyzed by flow cytometry.
Karyotype analysis
FISH and its subsequent analysis were performed as
described before [23]. Slides hydrated in PBS were fixed
in 4% v/v formaldehyde: PBS, washed 3 × 5 min in PBS,
treated with 0.1 mg/mL pepsin (P-70000, Sigma)a tp H
2 (3 min for fibroblasts, 1 1/2 min for lymphoblastoids),
followed by repeated formaldehyde fixation and PBS
washes before dehydration in an ethanol series (70%,
90% and 100%). Air-dried slides were first denatured at
80°C for 3 min with hybridization mixture containing
deionized formamide (F9037; Sigma), 0.5 μg/mL Cy-3-
conjugated-(CCCTAA)3 PNA probe complementary to
telomeric sequence and 3 μg/mL Fluorescein isothiocya-
nate (FITC)-conjugated-centromic PNA probe (Applied
Biosystems) in 10 mM Tris (pH 7), then hybridized in
the dark for 2 h at room temperature. Slides were then
washed 2 × 15 min in 70% v/v formamide (Merck)/1%
w/v BSA/10 mM Tris (pH 7.4) and 3 × 5 minute in 0.1
MT r i s( 1
st Base, Singapore)/0.15 M NaCl (pH 7.2)/
0.08% v/v Tween 20 (Sigma). Slides were dehydrated in
an ethanol series, air-dried in the dark and counter-
stained with 0.0375 μg/mL DAPI in mounting media
(Vectashield; Vector Laboratories). Images from approxi-
mately 50 metaphases were captured using an Axioplan
2 imaging fluorescent microscope (Zeiss) and analyzed
for chromosomal aberrationss u c ha sb r e a k so rf u s i o n s ,
which are indicative of genomic instability, with Isis
Imaging Software (Metasystems, Germany).
Results
Establishment of UHRF1-depleted cell lines
To investigate the requirement of UHRF1 in genome
integrity, we derived stable clones of HeLa cells expres-
sing shRNA targeted to UHRF1. Three clones were
selected that exhibited dramatically reduced UHRF1
expression, as demonstrated by Western analysis with
anti-UHRF1 (Figure 1A). Cells expressing the first
UHRF1 shRNA (UHRF1 shRNA cell line 1 and 2) or the
second UHRF1 shRNA (cell line 3) showed a drastic
depletion of UHRF1 protein levels compared to the
three cell lines expressing control shRNA. Previous stu-
dies have demonstrated a role for UHRF1 in mainte-
nance of heterochromatin organization and replication
[6,7,24]. To examine the heterochromatin status in
UHRF1-depleted cells, we immunostained UHRF1-
depleted and control cells with antibodies against
heterochromatin markers H3K9me3 and H4K20me3.
Control cell lines exhibited focal nuclear staining of
H3K9me3 and H4K20me3 that superimposed DAPI-
dense regions of nuclear chromatin that represent het-
erochromatin (Figure 1B-D). In marked contrast,
UHRF1-depleted cells showed loss of focal H3K9me3
accumulation, with H3K9me3 staining redistributed at
the nuclear periphery (Figure 1C). The impact on
H3K9me3 did not appear to reflect a generalized disrup-
tion of heterochromatin structure, as UHRF1-depleted
cells displayed focal staining of H4K20me3 that was
equivalent to that observed in control shRNA cell lines,
although H4K20me3 appeared to be localized in larger
focal regions than in control cells (Figure 1D). In both
control and UHRF1-depleted lines, no fluctuation in
either H3K9me3 or H4K20me3 staining was observed as
a consequence of cell cycle position. Taken together,
t h e s ef i n d i n g sd e m o n s t r a t eas ignificant reorganization
of heterochromatin in cells depleted of UHRF1.
Impact on proliferation and susceptibility to irradiation
Previous studies have documented that depletion of
UHRF1 results in proliferation arrest [5,25]. To assess
whether reducing levels of UHRF1 would impact cell
proliferation, we generated cell growth curves for
UHRF1 depleted and control lines (Figure 2A). UHRF1-
depleted cells proliferated at a slightly slower rate than
control cell lines, an effect that was only discernible fol-
lowing an extended (> 1 week) of analysis. Previous stu-
dies using murine embryonic stem cells with a targeted
disruption of Uhrf1 and human cells with reduced
UHRF1 have shown that these cells are more sensitive
to g-irradiation as analyzed by clonogenic assay [20,21].
To confirm these findings, two cell lines expressing
UHRF1 shRNAs and two cell lines expressing control
shRNAs were analyzed for sensitivity to g-irradiation by
clonogenic assay. As expected, cell lines depleted for
UHRF1 exhibited hypersensitivity to g-irradiation com-
pared to control cell lines (Figure 2B).
Cell cycle analysis following irradiation
To monitor capacity for cell cycle arrest following DNA
damage, we examined the percentage of cells at various
stages of the cell cycle for one UHRF1 shRNA cell line
and one control shRNA cell line following g-irradiation.
Cells were collected at various times after radiation (1
or 5 Gy) for cell cycle analysis following staining with
anti-BrdU and PI. In the absence of irradiation, UHRF1-
depleted cells showed a higher percentage of cells within
the G1 phase fraction and a decrease in the S phase
fraction compared to control-depleted cells (Figure 3A
and 3B). Following 1 Gy of irradiation, controls exhib-
ited a transient arrest in cell cycle progression with an
accumulation of cells in the G2/M fraction, a response
typical of HeLa cells. For control cells, this transient
arrest was maximal 12 h post-irradiation, with a nearly
four-fold increase in cell accumulation in the G2/M
fraction compared to non-irradiated cells (Figure 3A,
C-E). In contrast, UHRF1-depleted cells showed a
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Page 3 of 12Figure 1 Characterization of UHRF1-depleted HeLa cell lines.( A) Stable depletion of UHRF1 by shRNA in HeLa cells as shown by Western
analysis (UHRF1 shRNA clones 1-3) compared to clones expressing a nonspecific shRNA (control shRNA clones 1-3). Tubulin levels are shown as
loading controls. (B) Representative indirect immunofluorescence of H3K9me3 and H4K20me3 in control and UHRF1 shRNA cells at 40 ×
magnification. (C-D) Representative indirect immunofluorescence deconvolution of H3K9me3 and H4K20me3 in two UHRF1 shRNA and two
control shRNA cell lines. Line traces are shown on the right (blue = DAPI, red = H3K9me3 or H3K20me3) for representative photomicrographs
labeled with Greek characters.
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o n l yat w o - f o l di n c r e a s ei nt h eG 2 / Mf r a c t i o na n dn o
noticeable decline in the S phase fraction 12 h after irra-
diation compared to non-irradiated cells. By 24 h, cell
cycle progression resumed for both UHRF1-depleted
cells and controls. In contrast, the majority of cells irra-
diated with 5 Gy exhibited a more drastic arrest in cell
cycle progression leading to a predominant accumula-
tion of cells in the G2/M fraction, (Figure 3B). At 12 h
following 5 Gy, control cells accumulated in the G2/M
fraction compared to earlier time points; howver,
UHRF1-depleted cells showed a delayed accumulation in
G2/M compared to controls (Figure 3B).
gH2AX formation following g-irradiation
Phosphorylation of H2AX on serine 139 (gH2AX) is an
early event after introduction of DSBs [26]. To monitor
the kinetics and extent of gH2AX following irradiation,
we measured gH 2 A Xc o n t e n t0 ,1 ,3 ,6 ,1 2a n d2 4hi n
controls and UHRF1-depleted cells following 1 Gy or 5
Gy of g-irradiation (Figure 4). Non-irradiated cells
depleted of UHRF1 showed a nominally higher percen-
tage of cells positive for gH2AX compared to control
cells. Following 1 Gy of exposure, control cells showed a
dramatic increase in the percentage of cells positive for
gH2AX as expected, with maximal levels at 6 h that
decreased to a level similar to non-irradiated cells by 24
h (Figure 4A). This time course of gH2AX induction
corresponded to the degree of cell cycle arrest observed
at 1 Gy (Figure 3A). Interestingly, the percentage of
cells positive for gH2AX was markedly lower when
UHRF1 was depleted compared to control cells. Follow-
ing exposure to 5 Gy of irradiation, control cells showed
am o r ed r a s t i ci n c r e a s eo fgH2AX-positive cells with
maximal levels 1-6 h following irradiation. Again,
UHRF1-depleted cells showed an attenuated increase in
the percentage of gH2AX-positive cells (Figure 4B).
These findings were confirmed by detection of gH2AX
by indirect immunofluorescence (Figure 4C). Taken
together, these findings suggest that accumulation of
gH2AX is defective in UHRF1-depleted cells following
g-irradiation.
Micronuclei, centrosome copy number and karyotype
Given the compromised DNA damage response in
UHRF1-depleted cells, we sought to determine whether
UHRF1 depletion conferred chromosomal instability.
We stained three UHRF1-depleted and three control
cell lines with DAPI and scored incidence of micronu-
clei (Figure 5A-D). Micronuclei are cytoplasmic chro-
mosome fragments that fail to segregate properly during
mitosis and are excluded from daughter nuclei at telo-
phase [27,28]. Compared to the three control shRNA
cell lines, UHRF1 shRNA cell lines exhibited a higher
incidence of micronuclei (Figure 5E). We sought to
determine whether UHRF1 impacts centrosome status
Figure 2 Impact of UHRF1 loss on proliferation and sensitivity to g-irradiation.( A) Cell growth curves of UHRF1-depleted and control cell
lines. (B) Susceptibility of UHRF1-depleted cell lines to g-irradiation. Cell lines were exposed to ionizing radiation and sensitivity was measured by
colony formation.
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Page 5 of 12Figure 3 Cell cycle analysis in UHRF1-depleted cells following g-irradiation. UHRF1 or control shRNA-expressing cells were pulsed with
BrdU and then treated with 1 Gy (A) or 5 Gy (B)o fg-irradiation. Cells were harvested at the indicated times and stained with PI and for BrdU.
For each time point, representative DNA content histograms (PI stain) are shown on the left with corresponding BrdU-PI bivariate plots on the
right. Numerical values indicate percentage of G1, S and G2/M cells for each time point. The percentage change of cells in either G1 phase (C),
S phase (D) or G2/M phases (E) compared to non-irradiated cells are plotted as mean ± S.D. of three independent experiments (shown for 1 Gy).
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Page 6 of 12Figure 4 Decreased irradiation-induced gH2AX in UHRF1-depleted cells. UHRF1 and control shRNA-expressing cells were exposed to either
1G y( A) or 5 Gy (B) g-irradiation and harvested following 0, 1, 3, 6, 12 or 24 h. Representative histograms plot gH2AX expression as measured
by gH2AX-FITC intensity/cell (y-axis) vs. DNA content (x-axis) (left hand side of panel). Numbers indicate the percentage of cells showing
elevated gH2AX levels. The percentage of cells with elevated gH2AX expression plotted is the mean ± S.D. of three independent experiments
(right hand side of panel). (C) The decreased accumulation of gH2AX in UHRF1-depleted cells was confirmed by indirect immunofluorescence
12 h after 5 Gy g-irradiation.
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centrosome copy number following immunostaining
with g-tubulin revealed that the frequency of UHRF1-
depleted cells with 1 centrosome per cell was lower
compared to control cells and the frequency of UHRF1-
depleted cells with 2 or more centrosomes per cells was
higher compared to control cells (Figure 5F). To further
assess alterations in chromosome integrity, we con-
ducted karyotypic analyses on UHRF1-depleted and con-
trol cells. Visualization of telomeres and centromeres
during karyotyping further clarified the scoring of aber-
rant metaphase chromosomes. Consistent with our
observations of micronuclei and centrosomes, meta-
phase karyotypes of UHRF1-depleted cells showed a
dramatic increase in the number of cells containing
chromosome aberrations, particularly chromosome frag-
ments (Figure 5G-I and Table 1).
Discussion
Using cell lines designed to permanently express
reduced levels of UHRF1, we have demonstrated that
UHRF1 is essential for maintaining the DNA damage
response and genome integrity. Depletion of UHRF1
resulted in a greater propensity for cells to exhibit chro-
mosomal instability, as shown by the increased fre-
quency of micronuclei, supernumerary centrosomes and
chromosome fragments in UHRF1-depleted cells.
UHRF1 depleted cells exhibit increased susceptibility to
Figure 5 Chromosomal instability in UHRF1-depleted cells.( A-D) Representative photomicrographs showing presence of micronuclei in
UHRF1-depleted cells. (E) Percentage of cells with micronuclei in control cells vs. UHRF1-depleted cells. Determinations from each cell line were
performed in triplicate (n ≥ 200 cells/determination) and error bars represent standard deviations from the mean. (F) Percentage of control or
UHRF1-depleted cells with 1, 2, 3, or 4 centrosomes per cell. (G-I) Representative images of DAPI-stained metaphases from UHRF1-depleted cells
showing chromosomal aberrations (image shown in H is magnification of image in G). br = chromosome break, cf = centrosomal fragment,
af = acentric fragments. Telomeres are visualized in red, centromeres in green.
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arrest following DSB damage and decreased ability to
accumulate gH2AX.
Pericentric heterochromatin is the highly compacted
chromatin surrounding the centromere, a region that is
easily detected as DAPI-dense chromocenters in certain
cell lines. Recent studies have demonstrated several
important mechanisms whereby UHRF1 contributes to
the maintenance of heterochromatin. DNA replication
of heterochromatin presents several challenges, as the
cell replicates not only DNA but also the spatial organi-
zation of compacted chromatin regions. Heterochroma-
tin is characterized by hypermethylation of DNA and an
increased accumulation in certain post-translational
modifications to histones such as tri-methylation of his-
tones H3 and H4 at lysines 9 and 20 respectively.
UHRF1 is now considered to be a crucial component of
the protein machinery that ensures heterochromatin epi-
genetic markers are recreated on newly replicated
strands of DNA. UHRF1 plays an integral role in regen-
erating methylation of newly-replicated DNA by recruit-
ing the DNA methyltransferase DMNT1 [10,11]. In
addition, UHRF1 also binds to H3K9me3 which are
highly represented in heterochromatin. Recent studies
have reported conflicting results on the requirements of
UHRF1 for maintaining H3K9me3 in heterochromatin.
One report states that the heterochromatic distribution
of H3K9me3 in cells with stable depletion of UHRF1 by
shRNA was disrupted, with depleted cells showing dif-
fuse H3K9me3 staining compared to the focal hetero-
chromatic enrichment in control cells [7]. Our
observations confirm this finding, but contrast a subse-
quent study that does not report any significant changes
in the redistribution of heterochromatin markers such
a sH 3 K 9 m e 3i nN I H3 T 3c e l l sw i t hU H R F 1t r a n s i e n t l y
reduced by siRNA [24]. We suggest that the discrepancy
may be due to experimental methodology employed, in
that perhaps a transient reduction in UHRF1 levels will
not impact heterochromatin histone marker modifica-
tions to the same extent as long term depletion of
UHRF1.
We observed a slight impediment in the proliferation
ability of UHRF1-depleted cells compared to control cell
lines, in keeping with observations from previous studies
[5,9,17,25]. The impact of loss of UHRF1 on prolifera-
tive capacity of cells appears to vary on the cell model
used. UHRF1 depletion may impact S phase progression
due to a compromised ability to replicate heterochroma-
tin or through reversal of repressed expression of factors
that impede S phase entry, such as p21 [17]. Accord-
ingly, the overall effects of UHRF1 on proliferation
could vary in a cell-type dependent manner on the
degree of heterochromatin compaction and distribution.
Our analysis of non-irradiated UHRF1-depleted cells
revealed a decreased fraction of cells in S phase with a
corresponding increased fraction in G1 (not shown)
compared to control cells. This decreased tendency for
cells to be in S phase in the absence of UHRF1 has
been observed in prior studies [5,9,25]. A previous
report observed that loss of UHRF1 led a small fraction
of cells to be accumulated inG 1w h e nc h a l l e n g e dw i t h
doxorubicin, leading to the conclusion that loss of
UHRF1 unmasked a G1 checkpoint response to DNA
damage [4]. Although we see a similar increase in the
G1 peak of cells exposed to irradiation, we attribute this
to the cell cycle profile that the UHRF1-depleted cells
demonstrate prior to irradiation, and not as the result of
a novel checkpoint response to DNA damage.
Given the role of UHRF1 in maintenance of hetero-
chromatin structure and our findings that loss of UHRF1
compromises chromosomal integrity, we propose that
the genomic instability observed in UHRF1-depleted cells
is likely due to disruption of heterochromatin structure,
particularly the heterochromatin surrounding centro-
meres known as pericentric heterochromatin. Previous
studies have determined that maintenance of the
Table 1 Increased chromosomal instability in UHRF1-depleted cells
a.
Cell line Chromosome Breaks Chromatid Breaks Fusions Fragments Total No. of aberrations
Control
shRNA-1
00 1
(0.02/cell)
8
(0.16/cell)
9
(0.18/cell)
Control
shRNA-2
00 2
(0.04/cell)
12
(0.24/cell)
14
(0.28/cell)
Control
shRNA-3
2
(0.04/cell)
03
(0.06/cell)
10
(0.2/cell)
15
(0.3/cell)
UHRF1
shRNA-1
1
(0.02/cell)
05
(0.1/cell)
47
(0.94/cell)
53
(1.06/cell)
UHRF1
shRNA-2
1
(0.02/cell)
05
(0.1/cell)
51
(1.02/cell)
57
(1.14/cell)
UHRF1
shRNA-3
9
(0.18/cell)
1
(0.02/cell)
1
(0.02/cell)
54
(1.08/cell)
65
(1.3/cell)
aResults shown are number of chromosomal abnormalities detected in fifty metaphase spreads from three control shRNA and three UHRF1 shRNA (UHRF1-
depleted) cell lines. The frequency of a given abnormality/metaphase is shown below in parentheses.
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required to protect genomic stability [29,30]. In particu-
lar, loss of H3K9me3 in this form of heterochromatin by
the ablation of H3K9 methyltransferases Suv39h1 and
Suv39h2 is sufficient to compromise chromosome segre-
gation that could lead to the chromosomal aberrations
seen in UHRF1-depleted cells [30].
A variety of studies have shown that loss of UHRF1
activity leads to the sensitization of cells to a variety of
genotoxic agents including g-irradiation, however the
reason for this sensitivity has not been addressed
[20,21,25]. Here we have demonstrated UHRF1-depleted
cells exhibit an impaired ability to accumulate gH2AX
following irradiation. Surprisingly, these cells show a
reduced ability to generate gH2AX, a hallmark signal of
DSB repair despite the observation that loss of UHRF1
increases chromosomal instability and DSBs. Given the
role of UHRF1 in heterochromatin maintenance and
replication, our findings suggest that the chromatin mod-
ification properties of UHRF1 in heterochromatin are
required for an optimal response to DSB damage caused
by g-irradiation. Approximately 10% of all nucleosomes
in mammalian chromatin contain the histone H2A var-
iant H2AX. Following the initiation of DSB damage by
irradiation, the Mre11-Rad50-NBS1 (MRN) complex
binds to free DNA ends and recruits PIK-family protein
k i n a s e ss u c ha sA T M ,A T Ro rD N Ap r o t e i nk i n a s et h a t
cause the initial phosphorylation of H2AX on serine 139
(gH2AX). The recruitment of additional activated ATM
to DSBs by the gH2AX-binding protein MDC1 serves to
propagate the signal and amplify the focal accumulation
of gH2AX, which then serves as a beacon for other DNA
repair factors [reviewed in [31,32]].
Structural barriers of chromatin must be transiently
removed during processing of DNA damage and restored
following repair. Our findings of decreased gH2AX in
UHRF1-depleted cells suggest that the disruption of het-
erochromatin associated with loss of UHRF1 compro-
mises the accessibility of DNA damage response factors
to process and repair DSBs. Reducing the degree of chro-
matin compaction through the reduction of histone H1
levels or inhibition of histone deacetylase activity has
been demonstrated to increase the strength of the DNA
damage response by increasing the extent of signaling
generated per DNA lesion [33]. The focal phosphoryla-
tion of H2AX following g-irradiation has been shown to
occur less efficiently in heterochromatin compared to
euchromatin, suggesting that changes in the packaging
properties of chromatin have a marked impact on the
strength of gH2AX signal generated in cells [34,35].
A recent study using an in vitro approach reported
that UHRF1 can facilitate access of modifying enzymes
to DNA encased in nucleosomal arrays [24]. We pro-
pose that UHRF1 may allow changes in heterochromatin
structure that permit access of DNA surveillance and
repair enzymes and that loss of this property may be
responsible for the impaired DNA damage response
observed in cells with reduced UHRF1. For example,
our group and others show that stable reduction in
UHRF1 does not change the total amount of H3K9me3
in cells but disrupts the focal heterochromatin enrich-
ment of H3K9me3 normally observed in cells [7]. The
methylation status of histone H3 on lysine 9 has not
been reported to fluctuate in response to DNA damage,
but serves as a binding scaffold for several heterochro-
matin proteins such as members of the HP1 family that
have recently been implicated in the DNA damage
response [36-38]. Release of HP-1b bound to chromatin
by disruption of its H3K9me-associated binding domain
facilitates formation of gH2AX foci and loss of HP1-b
has been shown to result increased chromosomal
instability [36,39]. In contrast, heterochromatin proteins
HP1-a,H P 1 - b,a n dH P 1 - g were shown to be recruited
and accumulate at sites of DNA damage in a manner
that is independent of H3K9me3 status [38]. Changes in
heterochromatin modifications such as H3K9me3 and
HP1 binding distribution could impact other factors
that bind to HP1 proteins such as KAP-1, a protein
recently shown to facilitate the ATM-mediated repair of
DSBs in heterochromatin [37,40] or the histone acetyl-
transferase Tip60, which is activated by association with
H3K9me3 [41]. Given that the extent and distribution of
H3K9 methylation differs among cell lineages and is
altered in human tumours, changes in methylation sig-
natures of heterochromatin may contribute to the extent
of genomic instability in tumour cells or to the thera-
peutic efficacy of antineoplastics by impacting the effi-
cacy of DNA repair at specific chromatin regions in a
cell-type specific manner [42,43].
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